Details of the Drug Formulaction

General Information of Drug Formulation (ID: F09896)

• Formulation Name: Hydroxyurea 200 mg capsule
• Company: E.R. Squibb & Sons

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Hydroxyurea	(DMOQVU9)	Chronic myelogenous leukaemia	2A20.0	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Citric acid monohydrate	(E00271)	22230	Acidulant; Antioxidant; Buffering agent; Complexing agent; Flavoring agent
FD&C blue no. 1	(E00263)	19700	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent